Síndrome de Sjögren primario y linfoproliferación

Medicina Clinica

Volumn 114, Issue 19, 2000, Pages 740-746

  García Carrasco, Mario ^b   Ramos Casals, Manuel ^b   Cervera, Ricard ^b   Font Franco, Josep ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; NONHODGKIN LYMPHOMA; PROGNOSIS; REVIEW; SJOEGREN SYNDROME;

HUMANS; LYMPHOMA, NON-HODGKIN; PROGNOSIS; SJOGREN'S SYNDROME;

EID: 18344413610     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(00)71420-5     Document Type: Review

References (94)

1. García-Carrasco M, Ramos-Casals M, Cervera R. Síndrome de Sjögren. En: Rojas-Rodríguez J, García-Carrasco M, Cervera R, Font J, editores. Enfermedades autoinmunes sistémicas y reumáticas. Barcelona: Ediciones Doyma, 1997; 99-105.
2. Moutsopoulos HM. Sjögren's syndrome: autoimmune epithelitis. Clin Immunol Immunopathol 1994; 72: 162-165.
3. Anaya JM, Gutiérrez M, Espinosa LR. Síndrome de Sjögren primario. Manifestaciones clínicas extraglandulares. Rev Esp Reumatol 1994; 21: 337-342.
4. Ramos M, Cervera R, García-Carrasco M, Miret C, Muñoz FJ, Espinosa G et al. Síndrome de Sjögren primario: características clínicas e inmunológicas en una serie de 80 pacientes. Med Clin (Barc) 1997; 108: 652-657.
5. Ramos-Casals M, Cervera R, Font J, García-Carrasco M, Espinosa G, Reino S et al. Young onset of primary Sjögren's syndrome: clinical and immunological characteristics. Lupus 1998; 7: 202-206.
6. García-Carrasco M, Cervera R, Rosas J, Ramos-Casals M, Morlà RM, Cervera R et al. Primary Sjögren's syndrome in the elderly: clinical and immunological characteristics. Lupus 1998; 8: 20-23.
7. Font J, Ramos-Casals M, Cervera R, Bosch X, Mirapeix E, García-Carrasco M et al. Antineutrophil cytoplasmic antibodies in primary Sjögren's syndrome: prevalence and clinical significance. Br J Rheumatol 1998. 37: 1287-1291.
8. Cervera R, Font J, Ramos-Casals M, García-Carrasco M, Rosas J, Morlà RM et al. Primary Sjögren's syndrome in men: clinical and immunological characteristics. Lupus 2000. En prensa.
9. Rothman S, Bloch M, Hauser FV. Sjögren's syndrome associated with lymphoblastoma and hypersplenism. Arch Dermatol Syph 1951; 63: 642.
10. Talal N, Bunim JJ. Development of malignant lymphoma in the course of Sjögren's syndrome. Am J Med 1964; 36: 529-540.
11. Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978; 89: 888-892.
12. Valesini G, Priori R, Bavoillot D, Osborn J, Danieli MG, Del Papa N et al. Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome. J Rheumatol 1997; 24: 2376-2380.
13. Kruize AA, Hené RJ, Van der Heide A, Bodeutsch C, De Wilde PC, Von Vijsterdeld OP et al. Long-term follow-up of patients with Sjögren's syndrome. Arthritis Rheum 1996; 39: 297-303.
14. Pisa EK, Pisa P, Kang HI, Fox RI. High frequency of t(14;18) translocation in salivary gland lymphomas from Sjogren's syndrome patients. J Exp Med 1991; 174: 1245-1250.
15. Tapiros NI, Polihronis M, Moutsopoulos HM. Lymphoma development in Sjogren's syndrome. Novel p53 mutations. Arthritis Rheum 1999; 42: 1466-1472.
16. Guo K, Major G, Foster H, Bassendine M, Collier J, Ross D et al. Defective repair of 06-methylguanine-DNA in primary Sjögren's syndrome patients predisposed to lymphoma. Ann Rheum Dis 1995; 54: 229-232.
17. Ramos-Casals M, García-Carrasco M, Cervera R, Font J. Virus y síndrome de Sjögren. Rev Esp Reumatol 1999; 26: 310-317.
18. Fox RI, Saito I, Chan EK, Josephs S, Salahuddin SZ, Ahlashi DV et al. Viral genomes in lymphomas of patients with Sjögren's syndrome. J Autoimmun 1989; 2: 449-455.
19. Jeffers M, Crilly A, Kerr T, Richmond J, Madhok R. Non-Hodgkin's lymphomas complicating Sjögren's syndrome: can Epstein Barr virus be implicated? Scand J Rheumatol 1997; 26: 180-183.
20. Jarrett RF, Gledhill S, Qureshi F, Crae SH, Madhok R, Brown I et al. Identification of human herpesvirus 6-specific DNA sequences in two patients with non-Hodgkin's lymphoma. Leukemia 1988; 2: 496-502.
21. García-Carrasco M, Ramos-Casals M, Cervera R, Font J. Síndrome de Sjögren e infección por el virus de la hepatitis C. Rev Esp Reumatol 1997; 24: 220-225.
22. Haddad J, Deny P, Munz-Gotheil C, Ambrosini JC, Trinchet JC, Pateron D et al. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992; 339: 321-323.
23. García-Carrasco M, Ramos M, Cervera R, Font J, Vidal J, Muñoz F et al. Hepatitis C virus infection in «primary» Sjögren's syndrome: prevalence and clinical significance in a series of 90 patients. Ann Rheum Dis 1997; 56: 1-3.
24. Jorgensen C, Legouffe MC, Perney P, Coste J, Tissot B, Segarra C et al. Sicca syndrome associated with hepatitis C virus infection. Arthritis Rheum 1996; 39: 1166-1171.
25. Koike K, Moriya K, Ishibashi K, Yotsuyanagi H, Shintani Y, Fujie H et al. Sialadenitis histologically resembling Sjögren syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Natl Acad Sci USA 1997; 94: 233-236.
26. Ferri C, La Civita L, Caracciolo F, Zignego AL. Non-Hodgkin's lymphoma: a possible role of hepatitis C virus infection. JAMA 1994; 272: 355-356.
27. Pozzato G, Mazzaro C, Santini GF, Burrone O. Hepatitis C virus and non-Hodgkin's lymphoma. Leuk Lymphoma 1996; 22: 53.
28. Silvestri F, Pipan C, Barillari G, Zaja F, Farr n R, Infanti L et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996; 87: 4296.
29. De Vita S, Sacco C, Sansonno D, Gloghini A, Dammacco F, Crovatto M et al. Characterization of overt B-cell iymphomas in patients with hepatitis C virus infection. Blood 1997; 90: 776-782.
30. Thieblemont C, Berger F, Coiffier B. Mucosa-associated lymphoic tissue lymphomas. Curr Opin Oncol 1995; 7 415-420.
31. Sansonno D, Dammacco F. Hepatitis C virus c100 antigen in liver tissue from patients with acute and chronic infection. Hepatology 1993; 18: 240.
32. Sansonno D, Cornacchiulo V, Iacobelli AR, Di Stefano R, Lospalluti M, Dammacco F et al. Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. Hepatology 1995; 21: 305.
33. De Vita S, Sansonno D, Dolcetti R, Ferraccioli G, Carbone A, Cornacchiulo V et al. Hepatitis C virus infection within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood 1995; 86: 1887.
34. Ferri C, Monti M, La Civita L, Longombardo G, Greco F, Pasero G et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 1993; 82: 3701-3704.
35. Ramos-Casals M, García-Carrasco M, Cervera R, Font J. Síndrome de Sjögren e infección por el VHC. Med Clin (Barc) 1999; 112: 46.
36. Ramos-Casals M, García-Carrasco M, Cervera R, Font J. Sjögren's syndrome and hepatitis C virus. Clin Rheumatol 1998; 18: 93-100.
37. De Vita S, Ferraccioli G, Avellini C, Sorrentino D, Dolcetti R, Di Loreto C et al. Widespread clonal B-cell disorder in Sjogren's syndrome predisposing to Helicobacter pylori-related gastric lymphoma. Gastroenterology 1996; 110: 1969-1974.
38. Ferraccioli GF, Sorrentino D, De Vita S, Casatta L, Labombarda A, Avellini C et al. B cell clonality in gastric lymphoid tissues of patients with Sjogren's syndrome. Ann Rheum Dis 1996; 55: 311-316.
39. Harris NL, Jaffe ES, Stein H. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 1994; 84: 1361-1392.
40. Cogliatti SB, Lennert K, Hansmann ML, Zwingers TL. Monocytoid B cell lymphoma: clinical and prognostic features of 21 patients. J Clin Pathol 1990; 43: 619-625.
41. Wilke WS, Tubbs RR, Bukowski RM, Currie TE, Calabrese LH, Weiss RA et al. T cell lymphoma occurring in Sjogren's syndrome. Arthritis Rheum 1984; 27: 951-953.
42. Schuurman HJ, Gooszen HC, Tan IW, Kluin PM, Wagenaar SS, Van Unnik JA. Low-grade lymphoma of immature T-cell phenotype in a case of lymphocytic interstitial pneumonia and Sjogren's syndrome. Histopathology 1987; 11: 1193-1204.
43. Rustin MH, Isenberg DA, Griffiths MH, Gilkes JJ. Sjogren's syndrome and pleomorphic T-cell lymphoma presenting with skin involvement. J R Soc Med 1988; 81: 47-49.
44. Van der Valk PG, Hollema H, Van Voorst Vander PC, Brinker MG, Poppema S. Sjogren's syndrome with specific cutaneous manifestations and multifocal clonal T-cell populations progressing to a cutaneous pleomorphic T-cell lymphoma. Am J Clin Pathol 1989; 92: 357-361
45. Chevalier X, Gaulard P, Voisin MC, Martigny J, Farcet JP, Larget-Piet B. Peripheral T cell lymphoma with Sjogren's syndrome: a report with immunologic and genotypic studies. J Rheumatol 1991; 18: 1744-1746.
46. Ros S, Gómez C, Nolla JM, Roig-Escofet D. Linfoma pulmonar angiocéntrico de células T asociado a síndrome de Sjögren primario. Med Clin (Barc) 1996; 107: 117-118.
47. Vivancos J, Bosch X, Grau JM, Coca A, Font J. Development of Hodgkin's disease in the course of primary Sjogren's syndrome. Br J Rheumatol 1992; 31: 551-563.
48. Martín-Santos JM, Carretero L, Armentia A, Alonso E, Gil I. Hodgkin's disease occurring in primary Sjogrens syndrome. Ann Rheum Dis 1990; 49: 546-647.
49. Nagai M, Sasaki K, Tokuda M, Tasaka T, Goto T, Ohnishi M et al. Hodgkin's disease and Sjogren's syndrome. Eur J Haematol 1993; 50: 180-182
50. Gaches F, Álvarez M, Couret B, Mazerolles C, Delsol G, Arlet-Suau E. Hodgkin disease with cellular markers of Epstein-Barr virus complicating the course of Gougerot-Sjogren syndrome. Rev Med Interne 1997; 18: 79-80.
51. Iijima M, Suzuki N, Arata M. A case of Sjögren's syndrome associated with extramedullary myeloma. Jpn J Med 1989; 78: 618.
52. Shearn KA, Moutsopoulos HM, Sawada S, Gak C. Sjögren's syndrome with light chain myeloma. West J Med 1975; 123: 496-497.
53. Casaril M, Venturini L, Pecci R, Bonazi L, Menestrina F, Gabrielli GB et al. A case of parotideal myeloma in Sjogren's syndrome. Haematologica 1987; 72: 167-170.
54. Rodríguez-Cuartero A, Salas-Galán A. Sjogren's syndrome and multiple myeloma. Eur J Cancer 1997; 33: 167-168.
55. Ota T, Wake A, Eto S, Kobayashi T. Sjogren's syndrome terminating with multiple myeloma. Scand J Rheumatol 1995; 24: 316-318.
56. Takita H, Asai T, Nakamura M, Endoh N, Hiruma K, Igarashi T et al. Development of acute myelocytic leukemia in the course of Sjogren's syndrome. Rinsho Ketsueki 1989; 30: 56-60.
57. Bignon YJ, Janin-Mercier A, Dubost JJ, Ristori JM, Fonck Y, Alphonse JC et al. Angioimmunoblastic lymphadenopathy with dysproteinaemia (AILD) and sicca syndrome. Ann Rheum Dis 1986; 45: 519-522.
58. Kingsmore SF, Silva OE, Hall BD, Sheldon EA, Cripe LD, St Clair EW. Presentation of multicentric Castleman's disease with sicca syndrome, cardiomyopathy, palmar and plantar rash. J Rheumatol 1993; 20: 1588-1591.
59. Royer B, Cazals-Hatem D, Sibilia J, Agbalika F, Cayuela JM, Soussi T et al. Lymphomas in patients with Sjögren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood 1997; 90: 766-775.
60. Voulgarelis M, Dafni UG, Isenberg DA, Mousopoulos HM. Malignant lymphoma in primary Sjögren's syndrome. A multicenter, retrospective, clinical study by the European Concerted Action on Sj̈ogren's syndrome. Arthritis Rheum 1999; 42: 1765-1772.
61. Cacoub P, Ginsburg C, Tazi Z, Beaufils H, Charlotte F, Davi F et al. Sjogren's syndrome with acute renal failure caused by renal pseudolymphoma. Am J Kidney Dis 1996; 28: 762-766.
62. Takagi N, Nakamura S, Yamamoto K, Kunishima K, Takagi I, Suyama M et al. Malignant lymphoma of mucosa-associated lymphoid tissue arising in the thymus of a patient with Sjogren's syndrome. A morphologic, phenotypic, and genotypic study. Cancer 1992; 69: 1347-1355.
63. Jubert C, Cosnes A, Clerici T, Gaulard P, Andre P, Revuz J et al. Sjogren's syndrome and cutaneous B cell lymphoma revealed by anetoderma. Arthritis Rheum 1993; 36: 133-134.
64. Chazerain P, Meyer O, Kaplan G, Brissaud P, Delmer A, Zufferey P et al. Lymphomas of the ocular adnexa in Gougerot-Sjögren syndrome. Apropos of 4 cases. Ann Med Interne (Paris) 1995; 146: 223-225.
65. Moutsopoulos HM, Steinberg AD, Fauci AS, Lane HC, Papadopoulos NM. High incidence of free monoclonal light chains in the sera of patients with Sjögren's syndrome. J Immunol 1983; 130: 2263-2265.
66. Walters MT, Stevenson FK, Herbert A, Cawley MI, Smith JL. Urinary monoclonal free light chains in primary Sjogren's syndrome: an aid to the diagnosis of malignant lymphoma. Ann Rheum Dis 1986; 45: 210-219.
67. Ramos-Casals M, Font J. Crioglobulinemia mixta. ¿Esencial? Med Clin (Barc) 1999; 577-578.
68. Ramos-Casals M, Trejo O, Font J, Cervera R, García-Carrasco M, Yagüe J et al. Study of the etiology, clinical manifestations and immunological features of 200 patients with cryoglobulinemia. Arthritis Rheum 1999; 42 (Supl): 212.
69. Ramos-Casals M, Cervera R, Yagüe J, García-Carrasco M, Trejo O, Jiménez S et al. Cryoglobulinemia in primary SS: prevalence and clinical characteristics in a series of 115 patients. Semin Arthritis Rheum 1998; 28: 200-205.
70. Tzioufas AG, Boumba DS, Skopouli FN, Moutsopoulos HM. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome. Arthritis Rheum 1996; 39: 767-772.
71. Anaya JM, McGuff HS, Banks PM, Talal N. Clinicopathological factors relating malignant lymphoma with Sjögren's syndrome. Semin Arthritis Rheum 1996; 25: 337-346.
72. De Vita S, Ferraccioli G, De Re V, Carbone A, Tirelli V, Cassai E et al. The polymerase chain reaction detects B cell clonalities in patients with Sjogren's syndrome and suspected malignant lymphoma. J Rheumatol 1994; 21: 1497-1501.
73. Pablos JL, Carreira PE, Morillas L, Montalvo G, Ballestín C, Gómez-Reino JJ. Clonally expanded lymphocytes in the minor salivary glands of Sjogren's syndrome patients without lymphoproliferative disease. Arthritis Rheum 1994; 37: 1441-1444.
74. Jordan R, Diss TC, Lench NJ, lsaacson PG, Speight PM. Immunoglobulin gene rearrangements in lymphoplasmacytic infiltrates of labial salivary glands in Sjögren's syndrome. A possible predictor of lymphoma development. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 79: 723-729.
75. Diss TC, Peng H, Wotherspoon AC, Pan L, Speight PM, Isaacson PG. A single neoplastic clone in sequential biopsy specimens from a patient with primary gastricmucosa-associated lymphoid-tissue lymphoma and Sjogren's syndrome. N Engl J Med 1993; 329: 172-175.
76. Isaacson PG, Spencer J. Malignant lymphoma of mucossa-associated lymphoid tissue. Histopathology 1987; 11: 445-462.
77. Hornbaker JH Jr, Foster EA, Williams GS, Davis JS. Sjogren's syndrome and nodular reticulum cell sarcoma. Arch Intern Med 1966; 118: 449-452.
78. Miller DG. The association of immune disease and malignant lymphoma. Ann Intern Med 1967; 66: 507-521.
79. Sutcliffe N, Inanc M, Speight P, Isenberg D. Predictors of lymphoma development in pnmary Sjögren's syndrome. Semin Arthritis Rheum 1998; 28: 80-87.
80. Zufferey P, Meyer OC, Grossin M, Kahn MF. Primary Sjogren's syndrome (SS) and malignant lymphoma. A retrospective cohort study of 55 patients with SS. Scand J Rheumatol 1995; 24: 342-345.
81. Hernéndez JA, Olive A, Ribera JM, Tena X, Cuxart A, Feliu E. Probability of the development of non-Hodgkin's lymphoma in primary Sjogren's syndrome. Scand J Rheumatol 1996; 25: 396-397.
82. Cummings NA, Schall GL, Asofski R. Sjögren's syndrome. New aspects of research, diagnosis and therapy. Ann Intern Med 1971; 75: 937.
83. Strand V, Talal N. Advances in the diagnosis and concept of Sjögren's syndrome (autoimmune exocrinopathy). Bull Rheum Dis 1980; 30: 1046-1052.
84. Michalski JP, Daniels TE, Talal N, Grey HM. Beta 2 microglobulin and lymphocytic infiltration in Sjögren's syndrome. N Engl J Med 1975; 293: 1228-1231.
85. Manoussakis MN, Papadopoulos GK, Drosos AA, Moutsopoulos HM. Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune diseases. Clin Immunol Immunopathol 1989; 50: 321-332.
86. The international non-Hodgkin's lymphoma prognostic factors project: a predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987-994.
87. Tzusaka K, Akama H, Yamada H, Akizuki M, Tojo T, Homma M et al. Pulmonary pseudolymphoma presented with a mass lesion in a patient with primary Sjögren's syndrome: beneficial effect of intermittent intravenous cyclophosphamide. Scand J Rheumatol 1993; 22: 90-93.
88. Stewart A, Bleukinsopp PT, Henry K. Bilateral parotid MALT lymphoma and Sjögren's syndrome. Br J Oral Maxillofac Surg 1988; 32: 318-322.
89. Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ. Sjögren's syndrome: a clinical, pathological and serological study of sixty-two cases. Medicine 1965; 44: 187-231.
90. Whaley K, Webb J, McAvoy BA, Hughes GR, Lee P, Macsween RN et al. Siögren's syndrome. II. Clinical associations and immunological phenomena. Q J Med 1973; 42: 513-548.
91. McCurley TL, Collins RD, Ball E, Collins RD. Nodal and extranodal lymphoproliferative disorders in Sjogren's syndrome: a clinical and immunopathologic study. Hum Pathol 1990; 21: 482-492.
92. Kelly CA, Foster H, Pal B, Gardiner P, Malcolm AJ, Charles P et al. Primary Sjogren's syndrome in North East England. A longitudinal study. Br J Rheumatol 1991; 30: 437-442.
93. Pariente D, Anaya JM, Combe B, Jorgensen C, Emberger JM, Rossi JF et al. Non-Hodgkin's lymphoma associated with primary Sjogren's syndrome. Eur J Med 1992; 1: 337-342.
94. Pavlidis NA, Drosos AA, Papadimitriou C, Talal N, Moutsopoulos HM. Lymphoma in Sjogren's syndrome. Med Pediatr Oncol 1992; 20: 279-283.